You are here: / Industry Press Releases

JH Technologies Welcomes Electron Microscope (EM) Sample Preparation Expert Jerome Pons

July 31, 2018

JH Technologies, leading distributor of optical and digital imaging systems, materials preparation, testing and analysis systems and metrology tools announces that Jerome Pons recently joined the company at its headquarters in Fremont, Calif. as senior imaging specialist. Mr. Pons brings nearly 20 years of experience in electron microscopy, including developing new techniques to improve efficiency [...]

Edstrom Industries and Triple Red Combine to Become Avidity Science™

July 31, 2018

WATERFORD, Wis.-- Today Edstrom Industries, LLC and its UK-based subsidiary Triple Red Limited, announce they will unify the company under the name Avidity Science.  The change is a key part of the company's strategic plan to build a diversified research solutions business which exceeds the product and service needs of scientists and healthcare customers around the [...]

Fluidic Analytics Secures US Patent Paving the Way for the Development and Commercialisation of Next-generation Protein Analysis Technology Platform

July 31, 2018

Cambridge, UK Fluidic Analytics Ltd, has announced the issuance of US Patent 9,952,22 B2, entitled ‘Fluidic Separation and Detection’, from the United States Patent and Trademark Office. This paves the way for the development and commercialisation of a next-generation protein analysis technology platform to be launched later this year. "The issuance of the US Patent [...]

ACEA Biosciences Introduces an Exploratory xCELLigence® RTCA S16 Instrument

July 31, 2018

The new 16-well model uses a proprietary noninvasive biosensor technology to quantify cell proliferation, morphology changes, and adhesion in a label-free, real-time manner. xCELLigence S16 SAN DIEGO ACEA Biosciences, is a privately owned biotechnology company which develops cutting edge instrumentation for cell analysis. The company has just introduced the xCELLigence RTCA S16, which the ideal [...]

William Muzek joins Lifecycle Biotechnologies as Business Development Manager

July 31, 2018

FORT WORTH, Texas Lifecycle Biotechnologies, a leading life science tools and services supplier, welcomes William “Will” Muzek as Business Development Manager. In this role, Mr. Muzek will lead the company-wide industrial strategic business development efforts to achieve strategic goals and to accelerate Lifecycle’s continued growth and expansion. With over 20 years in business development, Mr. [...]

Providing more affordable full-length single-cell mRNA sequencing with industry-leading coverage and sensitivity for in-depth cellular characterization SOUTH SAN FRANCISCO, Calif., July 31, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced a new full-length single-cell mRNA sequencing application for the C1™ system that provides deep coverage and high sensitivity while reducing sample preparation costs by over 30%. Ideal for validation and further interrogation of new single-cell populations identified by ultra-high throughput methods, this new application expands the capability of the C1 to advance new single-cell discoveries. Because ultra-high throughput methods currently lack the coverage and sensitivity to go beyond cell identification and classification, researchers in the single-cell community have increasingly relied on full-length sequencing to confirm and characterize newly identified single-cell populations. To support this approach, Fluidigm researchers collaborated with New England Biolabs® (NEB®) to develop a more affordable full-length single-cell mRNA sequencing workflow for use with C1. Researchers can easily upgrade their C1 systems and download the new NEBNext® full-length cDNA Synthesis scripts and protocols through Script Hub™ for immediate use with C1 96 mRNA sequencing and C1 Open App™ 96 integrated fluidic circuits. “NEB recently launched its NEBNext Single Cell/Low Input RNA Library Prep Kit, which enables high sensitivity and reliability of transcript detection, and is pleased to be working with Fluidigm to support its use on the C1 system,” said Fiona Stewart, Next Generation Sequencing Portfolio Manager at NEB. “Single-cell biology is an important and growing area of life science research, with great potential in many fields, including cancer and neurobiology. We are excited that the combination of NEB’s and Fluidigm’s technologies will better meet the needs of researchers working in this area.” “We are pleased to offer the single-cell community with a more cost-effective method to validate and characterize ultra-high throughput studies,” said Chris Linthwaite, President and CEO of Fluidigm. “By bringing together the advantages of microfluidics technology with optimized chemistries from NEB, we believe this winning combination will enable researchers to further expand our overall understanding of health and disease at single-cell resolution.” About Fluidigm Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for markets such as mass cytometry, high-throughput genomics, and single‑cell genomics. We sell to leading academic institutions, clinical research laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures. We use our website (www.fluidigm.com), corporate Twitter account (@fluidigm), Facebook page (https://www.facebook.com/fluidigm), and LinkedIn page (https://www.linkedin.com/company/fluidigm-corporation) as channels of distribution of information about our products, our planned financial and other announcements, our attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and we may use these channels to comply with our disclosure obligations under Regulation FD. Therefore, investors should monitor our website and our social media accounts in addition to following our press releases, SEC filings, public conference calls, and webcasts. Fluidigm, the Fluidigm logo, C1, C1 Open App, and Script Hub are trademarks and/or registered trademarks of Fluidigm Corporation in the United States and/or other countries. All other trademarks are the sole property of their respective owners. Forward-Looking Statement for Fluidigm This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding the anticipated benefits of newly introduced products and the growth and potential of single-cell biology research. Forward-looking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from currently anticipated results, including but not limited to risks relating to challenges inherent in developing, manufacturing, launching, marketing, and selling new products; potential product performance and quality issues; intellectual property risks; and competition. Information on these and additional risks and uncertainties and other information affecting Fluidigm business and operating results is contained in Fluidigm’s Annual Report on Form 10-K for the year ended December 31, 2017, and in its other filings with the Securities and Exchange Commission, including the Fluidigm Quarterly Report on Form 10-Q for the quarter ended March 31, 2018. These forward-looking statements speak only as of the date hereof. Fluidigm disclaims any obligation to update these forward-looking statements except as may be required by law.

July 31, 2018

Didier Hirsch to Retire Oct. 31 Robert W. McMahon to Become Chief Financial Officer SANTA CLARA, Calif-- Agilent Technologies Inc. (NYSE:A) today announced that Didier Hirsch, senior vice president and chief financial officer, has decided to retire on Oct 31, 2018. The company has appointed Robert W. McMahon, currently chief financial officer, Hologic, Inc., as his successor. McMahon will join Agilenton August 3, as senior vice [...]

Fluidigm Introduces a Lower-Cost Workflow for Full-Length Single-Cell mRNA Sequencing on C1

July 31, 2018

Providing more affordable full-length single-cell mRNA sequencing with industry-leading coverage and sensitivity for in-depth cellular characterization SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced a new full-length single-cell mRNA sequencing application for the C1™ system that provides deep coverage and high sensitivity while reducing sample preparation costs [...]

10x Genomics Partners with BioLegend and Immudex to Extend Research Applications of Its New Single Cell Feature Barcoding Technology

July 31, 2018

PLEASANTON, CA.—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that BioLegend and Immudex will be the first 10x Compatible Partnersproviding products for its new single cell Feature Barcoding Technology, which was revealed at the 2018 Advances in Genome Biology and Technology meeting in February this year. The resulting product innovations, available at the end of 2018, will [...]

Pacific Biosciences Appoints Christian Henry to Board of Directors

July 31, 2018

Industry Veteran Previous Served as EVP & Chief Commercial Officer of Illumina  MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that it has appointed industry veteran Christian Henry to its Board of Directors. Mr. Henry has over 20 years of leadership experience, including over [...]

New Compact Refrigerators Designed for Secure and Sustainable Clinical Storage

July 31, 2018

The Thermo Scientific TSG Series of refrigerators maintain optimal cold storage conditions with minimal energy consumption and noise output CHICAGO, IL. – AACC 2018 - A new series of compact refrigerators has been specifically developed to address the need of clinical laboratories and patient care facilities for cold storage equipment that enable secure and energy-efficient [...]

Access IBO on Knowledge Center